tiprankstipranks
Syros Pharmaceuticals (SYRS)
NASDAQ:SYRS
Holding SYRS?
Track your performance easily

Syros Pharmaceuticals (SYRS) Income Statement

934 Followers

Syros Pharmaceuticals Income Statement

Last quarter (Q3 2024), Syros Pharmaceuticals's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q3, Syros Pharmaceuticals's net income was $-6.40M. See Syros Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 387.00K$ 9.94M$ 14.88M$ 23.49M$ 15.09M$ 1.98M
Cost of Revenue
------
Gross Profit
$ 387.00K$ 9.94M$ 14.88M$ 23.49M$ 15.10M$ 1.98M
Operating Expense
$ 109.56M$ 136.44M$ 141.24M$ 122.91M$ 97.39M$ 79.72M
Operating Income
$ -111.66M$ -128.99M$ -135.87M$ -99.42M$ -82.30M$ -77.74M
Net Non Operating Interest Income Expense
$ 689.00K$ 1.69M$ -2.00M$ -3.82M$ -1.37M$ 2.30M
Other Income Expense
$ -91.51M$ -39.76M$ 33.71M$ -16.68M$ 375.00K$ -100.00K
Pretax Income
$ -96.46M$ -164.57M$ -94.65M$ -86.56M$ -84.03M$ -75.44M
Tax Provision
$ 1.00K$ 1.00K$ 3.00K$ 1.00K$ 4.00K$ 28.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -97.81M$ -164.57M$ -94.65M$ -86.56M$ -84.04M$ -75.44M
Basic EPS
$ -3.08$ -5.81$ -7.49$ -13.80$ -18.20$ -18.80
Diluted EPS
$ -3.08$ -5.81$ -7.49$ -13.80$ -18.20$ -18.80
Basic Average Shares
$ 147.14M$ 28.33M$ 12.63M$ 6.25M$ 4.61M$ 4.02M
Diluted Average Shares
$ 147.14M$ 28.33M$ 12.63M-$ 4.61M$ 4.02M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 112.05M$ 136.44M$ 141.24M$ 122.91M$ 97.39M$ 79.72M
Net Income From Continuing And Discontinued Operation
$ -97.81M$ -164.57M$ -94.65M$ -86.56M$ -84.04M$ -75.44M
Normalized Income
$ -81.53M$ -126.52M-$ -68.38M--
Interest Expense
------
EBIT
$ -93.80M$ -159.45M$ -90.52M$ -82.65M$ -82.25M$ -75.37M
EBITDA
$ -92.03M$ -157.19M$ -87.81M$ -79.63M$ -79.21M$ -73.61M
Currency in USD

Syros Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis